Search Results 231-240 of 18778 for amyloidosis
This is a much higher rate than the 3.7% occurrence of cardiac amyloidosis typically found at autopsy in patients at Mayo Clinic. It suggests that this ...
... Amyloidosis. Print details. Share; Facebook · Twitter. Overview; Participation ... amyloidosis, such as heart failure. Participation eligibility. Participant ...
Discovery's Edge: Cell research on amyloidosis featured image · Research · Discovery's Edge: How Mayo is Transforming Medicine featured image · Schools within Mayo ...
Vutrisiran injection is used to treat polyneuropathy (nerve disease) of hereditary transthyretin-mediated amyloidosis (hATTR-PN). This medicine is also used ...
... Amyloidosis. Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting ...
Amyloidosis. Proteins build up around the organs, including the heart. The collection of proteins interferes with how the organs work. When the condition is ...
Rochester, Minn. The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR).
Clinical Interest — multiple myeloma, amyloidosis, other plasma cell disorders · Research Interests — patient reported outcomes, quality of life, and health care ...
... amyloidosis, immunotactoid glomerulopathy, monoclonal immunoglobulin deposition disease, crystalglobulin-induced nephropathy, myeloproliferative neoplasm ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!